Page 80 - Development Strategy News Today

KUCHING (Oct 4): The 27th World Congress on Innovation and Technology 2023 and the 6th International Digital Economy Conference Sarawak (WCIT | IDECS 2023) saw visitors from various professional backgrounds converging at Borneo Convention Centre Kuching (BCCK). Awang Naeem, 25, who works as a pro

KUCHING, Oct 3 — Premier Tan Sri Abang Johari Openg today pledged that Sarawak will continue to lead the green economy agenda in the region for sustainable development in line...

KUCHING: Sarawak-based Global Resources Management Digital Solutions Sdn Bhd (GRM) is planning to set up four advanced artificial intelligence (AI) data centres in Malaysia and Singapore.

Uzbekistan joined the UN as a new sovereign, independent state on March 2, 1992. Since joining this universal international organization, our country has been productively cooperating with it and its specialized institutions in various areas. The main priorities of multilateral cooperation are the fight against modern threats and security challenges, the stabilization and restoration of […]

MARUDI (Sept 30): Sarawakians must continue to 'paddle in rhythm' so that its leaders can continue to focus on developing the state in line with the Post Covid-19 Development Strategy 2030 (PCDS 2030), said Premier Datuk Patinggi Tan Sri Abang Johari Tun Openg. He said that the unity and peace en

Grant Fleming joins as Vice President, Food & Beverage and Nuno Moreira is appointed Vice President, Strategy & Commercial

DUBLIN, Ireland, Sept. 29, 2023 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders, today provided updates

DUBLIN, Ireland, Sept. 29, 2023 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders, today provided updates and guidance on its clinical development program for GH001, its proprietary inhalable mebufotenin (5-MeO-DMT) product candidate, in treatment-resistant depression (TRD). Development Strategy As previously announced, following successful completion of our Phase 1/2 tr

DUBLIN, Ireland, Sept. 29, 2023 -- GH Research PLC , a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders, today provided...

MANAGEMENTS DISCUSSION AND ANALYSIS Three and Six Months Ended July 31, 2023 This following Managements Discussion and Analysis is prepared as of September...